22 - 139 - SYSTEMIC NECROTIZING ARTERITIS

Question 1

Behcet disease is markedly more common in these countries, except one:

A. Eastern Mediterranean

B. Northern Europe

C. Korea

D. Japan

Answer 1

B

Question 2

Infection-related vasculitis: _____ in many cases of polyarteritis nodosa

A. Hepatitis B virus

B. Hepatitis C virus

C. EBV

D. Parvovirus

Answer 2

A

Question 3

HLA locus in giant cell arteritis

A. Class I

B. Class II

C. Class III

D. Class IV

Answer 3

B

Question 4

For drug-induced vasculitis, it is useful to ask about prescription, nonprescription, and “alternative” or herbal medication use in the prior

A. 1 to 3 months

B. 3 to 6 months

C. 6 to 12 months

D. >12 months

Answer 4

C

Question 5

Tests for _____ are the most important to order in evaluating a patient suspected of having vasculitis

A. Cardiac disease

B. Hematologic disease

C. Liver disease

D. Renal disease

Question 6

90% of patients with _____ will test positive for ANCA

A. Granulomatosis with polyangiitis

B. Eosinophilic granulomatosis with polyangiitis

C. Granulomatous with polyangiitis

D. Microscopic polyangiitis

Answer 6

D

Question 7

Cutaneous leukocytoclastic angiitis: _____% of cases follow a wide range of infections

A. 10

B. 20

C. 30

D. 40

Answer 7

B

Question 8

Typical presentation of Takayasu arteritis

A. Pulselessness

B.Ulcer

C.claudication

D.Purpura

Answer 8

C

Question 9

Mainstay of therapy for vasculitis

A. Glucocorticoids

B. Methotrexate

C. Glucocorticoid + Methotrexate

D. Glucocorticoid + Cyclophosphamide

Answer 9

A

Question 10

Monoclonal antibody to anti-interleukin 5 Demonstrated to have efficacy in the treatment of eosinophilic granulomatosis with polyangiitis

A. Tocilizumab

B. Rituximab

C. Dupilumab

D. Mepolizumab

Answer 10

D